Showing results (51-60 of 244) with videos related to
Sort By:
Pageof 25
Journal of Virology|December 17, 2010
Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibodyKonduru S R Sastry, Chien Tei Too, Kaval Kaur, et al.The Lancet. Gastroenterology & Hepatology|July 27, 2025
Scientific and medical evidence informing expansion of hepatitis B treatment guidelinesPatrick T Kennedy, Lena Allweiss, Antonio Bertoletti, et al.Methods in Molecular Biology (Clifton, N.J.)|July 23, 2024
Optimized Ex Vivo Fluorospot Assay to Measure Multifunctional HBV-Specific T Cell Frequencies in Chronic Hepatitis B PatientsConan Chua, Mireia García-López, Adam J GehringAntiviral Therapy|November 3, 2010
The host-pathogen interaction during HBV infection: immunological controversiesAntonio Bertoletti, Mala K Maini, Carlo FerrariCytotherapy|August 30, 2017
T-cell therapy for chronic viral hepatitisAntonio Bertoletti, Anthony Tanoto Tan, Sarene KohHepatology (Baltimore, Md.)|April 1, 2025
Getting to HBV Cure - will new biomarkers help?Jordan J Feld, Adam J Gehring, Fabien ZoulimMethods in Molecular Biology (Clifton, N.J.)|August 28, 2025
mRNA-Based Engineering of Viral Antigen-Specific TCR-T CellsHe Shan, Antonio Bertoletti, Anthony Tanoto TanSeminars in Immunology|November 7, 2025
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectivenessShan He, Anthony T Tan, Antonio BertolettiIntervirology|July 19, 2014
Host factor-targeted hepatitis B virus therapiesAdam Gehring, Antonio Bertoletti, John E TavisMolecular Therapy. Nucleic Acids|August 15, 2013
A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virusSarene Koh, Noriko Shimasaki, Rossarin Suwanarusk, et al.Pageof 25